Cargando…

Response to the hunt for the perfect biomarker in nasopharyngeal carcinoma—the RRAS “race” beyond Epstein-barr virus?

Detalles Bibliográficos
Autores principales:	Xiao, Ruowen, Mai, Shijuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798163/ https://www.ncbi.nlm.nih.gov/pubmed/35117004 http://dx.doi.org/10.21037/tcr.2019.10.01

Ejemplares similares

The Hunt for the perfect biomarker in nasopharyngeal carcinoma—the RRAS “race” beyond Epstein-Barr virus?
por: Tan, Mark T. L., et al.
Publicado: (2019)

Identification of RRAS gene related to nasopharyngeal carcinoma based on pathway and network-based analyses
por: Xiao, Ruowen, et al.
Publicado: (2019)

In Response to: Pediatric Myelodysplastic Syndrome with Germline RRAS Mutation: Expanding the Phenotype of RASopathies
por: van Engelen, Nienke, et al.
Publicado: (2022)

Epstein-Barr virus and nasopharyngeal carcinoma
por: Young, Lawrence S., et al.
Publicado: (2014)

Epstein-Barr virus gastric ulcer associated with ruxolitinib
por: Kusano, Yoshiharu, et al.
Publicado: (2016)

Evidence of Epstein–Barr Virus in Female Breast Cancer
por: ALINEZHAD, Farbod, et al.
Publicado: (2021)

Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma
por: Chan, K.C. Allen
Publicado: (2014)

Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma
por: Hau, Pok Man, et al.
Publicado: (2020)

The role of Epstein–Barr virus in nasopharyngeal carcinoma
por: Su, Zhi Yi, et al.
Publicado: (2023)

Roles of Inflammasomes in Epstein–Barr Virus-Associated Nasopharyngeal Cancer
por: Looi, Chin King, et al.
Publicado: (2021)

Is Epstein–Barr virus associated with aggressive forms of breast cancer?
por: Khan, G, et al.
Publicado: (2011)

Mild form of Guillain-Barré syndrome in a patient with primary Epstein-Barr virus infection
por: Kim, Se Yong, et al.
Publicado: (2016)

Reply: Is Epstein–Barr virus associated with aggressive forms of breast cancer?
por: Mazouni, C, et al.
Publicado: (2011)

The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma
por: Li, You Quan, et al.
Publicado: (2018)

Role of Epstein-Barr Virus in the Development of Nasopharyngeal Carcinoma
por: Zhang, Hui, et al.
Publicado: (2017)

Elderly‐onset systemic Epstein–Barr virus‐positive T‐cell lymphoma of childhood
por: Nishikubo, Masashi, et al.
Publicado: (2022)

Epstein–Barr virus acute acalculous cholecystitis
por: Vermaak, Jacobus S.
Publicado: (2021)

Hydroa Vacciniforme-Like Eruption Associated with Epstein-Barr Virus Infection in an Older Adult
por: Jung, Soo-Eun, et al.
Publicado: (2015)

The Emergence of Epstein-Barr Virus-Related Diffuse Large B-Cell Lymphoma With Mogamulizumab
por: Wang, Lan, et al.
Publicado: (2020)

The influences of the COVID-19 pandemic on Epstein-Barr virus infection in children, Henan, China
por: Liang, Ying, et al.
Publicado: (2023)

Epstein-Barr virus infection and persistence in nasopharyngeal epithelial cells
por: Tsang, Chi Man, et al.
Publicado: (2014)

Epstein-Barr Virus Mediated Signaling in Nasopharyngeal Carcinoma Carcinogenesis
por: Richardo, Timmy, et al.
Publicado: (2020)

Nasopharyngeal Carcinoma: The Role of the EGFR in Epstein–Barr Virus Infection
por: Peng, Xintong, et al.
Publicado: (2021)

Prognostic value of serum Epstein–Barr virus antibodies in patients with nasopharyngeal carcinoma and undetectable pretreatment Epstein–Barr virus DNA
por: Yao, Ji‐Jin, et al.
Publicado: (2017)

Positivity of both plasma Epstein–Barr virus DNA and serum Epstein–Barr virus capsid specific immunoglobulin A is a better prognostic biomarker for nasopharyngeal carcinoma
por: Zhao, Fei-Peng, et al.
Publicado: (2014)

An Adult Case of Severe Chronic Active Epstein-Barr Virus Infection with T-Cell Lymphoproliferative Disorder
por: Mun, Se-Kwon, et al.
Publicado: (2012)

The microenvironment of classical Hodgkin lymphoma: heterogeneity by Epstein–Barr virus presence and location within the tumor
por: Wu, R, et al.
Publicado: (2016)

Comment on “The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to in vivo imaging”
por: Asadollahzade, Elnaz, et al.
Publicado: (2022)

Epstein-Barr virus in nasopharyngeal and salivary gland carcinomas of Greenland Eskimoes.
por: Saemundsen, A. K., et al.
Publicado: (1982)

Therapeutic implications of Epstein–Barr virus infection for the treatment of nasopharyngeal carcinoma
por: Hutajulu, Susanna Hilda, et al.
Publicado: (2014)

The Criteria to Confirm the Role of Epstein-Barr Virus in Nasopharyngeal Carcinoma Initiation
por: Gu, Ai-Di, et al.
Publicado: (2012)

Identification of genes involved in Epstein-Barr virus-associated nasopharyngeal carcinoma
por: Wang, Junguo, et al.
Publicado: (2016)

Correlation of nasopharyngeal carcinoma with rare earth elements and the Epstein-Barr virus
por: Zhang, Xiangmin, et al.
Publicado: (2018)

Rearranged Epstein‐Barr Virus Genomes and Clonal Origin in Nasopharyngeal Carcinoma
por: Shimakage, Misuzu, et al.
Publicado: (1989)

Progression of understanding for the role of Epstein-Barr virus and management of nasopharyngeal carcinoma
por: Nakanishi, Yosuke, et al.
Publicado: (2017)

Epstein-Barr Virus Glycoprotein Antibody Titers and Risk of Nasopharyngeal Carcinoma
por: Coghill, Anna E, et al.
Publicado: (2022)

Epstein-Barr Virus-Positive Primary Cutaneous Diffuse Large B-Cell Lymphoma in an Immunocompetent Patient
por: Park, Ji-Hye, et al.
Publicado: (2014)

RRas2, RhoG and T-cell phagocytosis
por: Alarcón, Balbino, et al.
Publicado: (2012)

Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein‐Barr virus associated nasopharyngeal carcinoma
por: Liu, Lingzhi, et al.
Publicado: (2019)

Evaluation of plasma Epstein–Barr virus DNA as a biomarker for Epstein–Barr virus–associated Hodgkin lymphoma
por: Usha, Masuma Khatun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r30r38n6j9sgtf6ihtsmpeoa07